Selected research
Industry Research
Ligases Enzymes Industry Research Report 2026
Market perspective
The global Ligases Enzymes market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ligases Enzymes is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ligases Enzymes is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ligases Enzymes is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ligases Enzymes include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ligases Enzymes market in revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Ligases Enzymes.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ligases Enzymes Market by Company
Agilent
BioRad
Illumina, Inc.
New England Biolabs
Promega
QIAGEN
Roche
Takara
Thermo Fisher Scientific
Abclonal
Fapon Biotech Inc
Novoprotein
CWbio
Vazyme
TransGen Biotech
Yeasen
Ligases Enzymes Segment by Type
DNA Ligase
RNA Ligase
Ligases Enzymes Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Academic & Research Institutes
Others
Ligases Enzymes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ligases Enzymes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ligases Enzymes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ligases Enzymes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ligases Enzymes manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ligases Enzymes by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ligases Enzymes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Ligase
- RNA Ligase
Applications
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Centers
- Academic & Research Institutes
- Others
Companies covered
- Agilent
- BioRad
- Illumina, Inc.
- New England Biolabs
- Promega
- QIAGEN
- Roche
- Takara
- Thermo Fisher Scientific
- Abclonal
- Fapon Biotech Inc
- Novoprotein
- CWbio
- Vazyme
- TransGen Biotech
- Yeasen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ligases Enzymes by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 DNA Ligase
- 2.2.3 RNA Ligase
- 2.3 Ligases Enzymes by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceutical & Biotechnology Companies
- 2.3.3 Hospitals & Diagnostic Centers
- 2.3.4 Academic & Research Institutes
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Ligases Enzymes Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Ligases Enzymes Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Ligases Enzymes Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Ligases Enzymes Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ligases Enzymes Production by Manufacturers (2021-2026)
- 3.2 Global Ligases Enzymes Production Value by Manufacturers (2021-2026)
- 3.3 Global Ligases Enzymes Average Price by Manufacturers (2021-2026)
- 3.4 Global Ligases Enzymes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ligases Enzymes Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Ligases Enzymes Manufacturers, Product Type & Application
- 3.7 Global Ligases Enzymes Manufacturers Established Date
- 3.8 Global Ligases Enzymes Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Agilent
- 4.1.1 Agilent Ligases Enzymes Company Information
- 4.1.2 Agilent Ligases Enzymes Business Overview
- 4.1.3 Agilent Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Agilent Product Portfolio
- 4.1.5 Agilent Recent Developments
- 4.2 BioRad
- 4.2.1 BioRad Ligases Enzymes Company Information
- 4.2.2 BioRad Ligases Enzymes Business Overview
- 4.2.3 BioRad Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 BioRad Product Portfolio
- 4.2.5 BioRad Recent Developments
- 4.3 Illumina, Inc.
- 4.3.1 Illumina, Inc. Ligases Enzymes Company Information
- 4.3.2 Illumina, Inc. Ligases Enzymes Business Overview
- 4.3.3 Illumina, Inc. Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Illumina, Inc. Product Portfolio
- 4.3.5 Illumina, Inc. Recent Developments
- 4.4 New England Biolabs
- 4.4.1 New England Biolabs Ligases Enzymes Company Information
- 4.4.2 New England Biolabs Ligases Enzymes Business Overview
- 4.4.3 New England Biolabs Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 New England Biolabs Product Portfolio
- 4.4.5 New England Biolabs Recent Developments
- 4.5 Promega
- 4.5.1 Promega Ligases Enzymes Company Information
- 4.5.2 Promega Ligases Enzymes Business Overview
- 4.5.3 Promega Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Promega Product Portfolio
- 4.5.5 Promega Recent Developments
- 4.6 QIAGEN
- 4.6.1 QIAGEN Ligases Enzymes Company Information
- 4.6.2 QIAGEN Ligases Enzymes Business Overview
- 4.6.3 QIAGEN Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 QIAGEN Product Portfolio
- 4.6.5 QIAGEN Recent Developments
- 4.7 Roche
- 4.7.1 Roche Ligases Enzymes Company Information
- 4.7.2 Roche Ligases Enzymes Business Overview
- 4.7.3 Roche Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Roche Product Portfolio
- 4.7.5 Roche Recent Developments
- 4.8 Takara
- 4.8.1 Takara Ligases Enzymes Company Information
- 4.8.2 Takara Ligases Enzymes Business Overview
- 4.8.3 Takara Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Takara Product Portfolio
- 4.8.5 Takara Recent Developments
- 4.9 Thermo Fisher Scientific
- 4.9.1 Thermo Fisher Scientific Ligases Enzymes Company Information
- 4.9.2 Thermo Fisher Scientific Ligases Enzymes Business Overview
- 4.9.3 Thermo Fisher Scientific Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Thermo Fisher Scientific Product Portfolio
- 4.9.5 Thermo Fisher Scientific Recent Developments
- 4.10 Abclonal
- 4.10.1 Abclonal Ligases Enzymes Company Information
- 4.10.2 Abclonal Ligases Enzymes Business Overview
- 4.10.3 Abclonal Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Abclonal Product Portfolio
- 4.10.5 Abclonal Recent Developments
- 4.11 Fapon Biotech Inc
- 4.11.1 Fapon Biotech Inc Ligases Enzymes Company Information
- 4.11.2 Fapon Biotech Inc Ligases Enzymes Business Overview
- 4.11.3 Fapon Biotech Inc Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Fapon Biotech Inc Product Portfolio
- 4.11.5 Fapon Biotech Inc Recent Developments
- 4.12 Novoprotein
- 4.12.1 Novoprotein Ligases Enzymes Company Information
- 4.12.2 Novoprotein Ligases Enzymes Business Overview
- 4.12.3 Novoprotein Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Novoprotein Product Portfolio
- 4.12.5 Novoprotein Recent Developments
- 4.13 CWbio
- 4.13.1 CWbio Ligases Enzymes Company Information
- 4.13.2 CWbio Ligases Enzymes Business Overview
- 4.13.3 CWbio Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 CWbio Product Portfolio
- 4.13.5 CWbio Recent Developments
- 4.14 Vazyme
- 4.14.1 Vazyme Ligases Enzymes Company Information
- 4.14.2 Vazyme Ligases Enzymes Business Overview
- 4.14.3 Vazyme Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Vazyme Product Portfolio
- 4.14.5 Vazyme Recent Developments
- 4.15 TransGen Biotech
- 4.15.1 TransGen Biotech Ligases Enzymes Company Information
- 4.15.2 TransGen Biotech Ligases Enzymes Business Overview
- 4.15.3 TransGen Biotech Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 TransGen Biotech Product Portfolio
- 4.15.5 TransGen Biotech Recent Developments
- 4.16 Yeasen
- 4.16.1 Yeasen Ligases Enzymes Company Information
- 4.16.2 Yeasen Ligases Enzymes Business Overview
- 4.16.3 Yeasen Ligases Enzymes Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Yeasen Product Portfolio
- 4.16.5 Yeasen Recent Developments
5 Global Ligases Enzymes Production by Region
- 5.1 Global Ligases Enzymes Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ligases Enzymes Production by Region: 2021-2032
- 5.2.1 Global Ligases Enzymes Production by Region: 2021-2026
- 5.2.2 Global Ligases Enzymes Production Forecast by Region (2027-2032)
- 5.3 Global Ligases Enzymes Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Ligases Enzymes Production Value by Region: 2021-2032
- 5.4.1 Global Ligases Enzymes Production Value by Region: 2021-2026
- 5.4.2 Global Ligases Enzymes Production Value Forecast by Region (2027-2032)
- 5.5 Global Ligases Enzymes Market Price Analysis by Region (2021-2026)
- 5.6 Global Ligases Enzymes Production and Value, YOY Growth
- 5.6.1 North America Ligases Enzymes Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Ligases Enzymes Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Ligases Enzymes Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Ligases Enzymes Production Value Estimates and Forecasts (2021-2032)
6 Global Ligases Enzymes Consumption by Region
- 6.1 Global Ligases Enzymes Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ligases Enzymes Consumption by Region (2021-2032)
- 6.2.1 Global Ligases Enzymes Consumption by Region: 2021-2026
- 6.2.2 Global Ligases Enzymes Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ligases Enzymes Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ligases Enzymes Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ligases Enzymes Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Ligases Enzymes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Ligases Enzymes Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Ligases Enzymes Production by Type (2021-2032)
- 7.1.1 Global Ligases Enzymes Production by Type (2021-2032) & (kg)
- 7.1.2 Global Ligases Enzymes Production Market Share by Type (2021-2032)
- 7.2 Global Ligases Enzymes Production Value by Type (2021-2032)
- 7.2.1 Global Ligases Enzymes Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Ligases Enzymes Production Value Market Share by Type (2021-2032)
- 7.3 Global Ligases Enzymes Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Ligases Enzymes Production by Application (2021-2032)
- 8.1.1 Global Ligases Enzymes Production by Application (2021-2032) & (kg)
- 8.1.2 Global Ligases Enzymes Production Market Share by Application (2021-2032)
- 8.2 Global Ligases Enzymes Production Value by Application (2021-2032)
- 8.2.1 Global Ligases Enzymes Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Ligases Enzymes Production Value Market Share by Application (2021-2032)
- 8.3 Global Ligases Enzymes Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Ligases Enzymes Value Chain Analysis
- 9.1.1 Ligases Enzymes Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Ligases Enzymes Production Mode & Process
- 9.2 Ligases Enzymes Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ligases Enzymes Distributors
- 9.2.3 Ligases Enzymes Customers
10 Global Ligases Enzymes Analyzing Market Dynamics
- 10.1 Ligases Enzymes Industry Trends
- 10.2 Ligases Enzymes Industry Drivers
- 10.3 Ligases Enzymes Industry Opportunities and Challenges
- 10.4 Ligases Enzymes Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst